A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody
Clinical trial NCT06021574 · COMPLETED
Trial details
- NCT number
- NCT06021574
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2020-01-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.